Finch Therapeutics Group Stock Price on April 27, 2021

FNCH Stock  USD 2.89  0.24  9.06%   
If you're considering investing in Finch Stock, it is important to understand the factors that can impact its price. As of today, the current price of Finch Therapeutics stands at 2.89, as last reported on the 28th of March, with the highest price reaching 3.16 and the lowest price hitting 2.64 during the day. Finch Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0209, which denotes the company had a -0.0209% return per unit of risk over the last 3 months. Finch Therapeutics Group exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Finch Therapeutics' Downside Deviation of 5.65, coefficient of variation of 14374.85, and Mean Deviation of 4.25 to check the risk estimate we provide.
  
As of now, Finch Therapeutics' Total Stockholder Equity is increasing as compared to previous years. The Finch Therapeutics' current Common Stock Shares Outstanding is estimated to increase to about 1.7 B, while Common Stock Total Equity is projected to decrease to 6,400. . As of now, Finch Therapeutics' Price To Book Ratio is increasing as compared to previous years. The Finch Therapeutics' current Price Sales Ratio is estimated to increase to about 56.8 K, while Price Earnings Ratio is forecasted to increase to (73.61). Finch Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0209

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsFNCH

Estimated Market Risk

 6.91
  actual daily
60
60% of assets are less volatile

Expected Return

 -0.14
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Finch Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Finch Therapeutics by adding Finch Therapeutics to a well-diversified portfolio.
Price Book
0.1645
Enterprise Value Ebitda
(0.12)
Price Sales
43.4321
Shares Float
784.6 K
Wall Street Target Price
90

Finch Therapeutics Valuation on April 27, 2021

It is possible to determine the worth of Finch Therapeutics on a given historical date. On April 27, 2021 Finch was worth 5.93 at the beginning of the trading date compared to the closed value of 150.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Finch Therapeutics stock. Still, in general, we apply an absolute valuation method to find Finch Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Finch Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Finch Therapeutics' related companies.
 Open High Low Close Volume
03/14/2022
  5.93    150.90    150.90    150.90    2,477  
  5.02    155.10    155.10    155.10    1,879  
Backtest Finch Therapeutics  |  Finch Therapeutics History  |  Finch Therapeutics Valuation Next  
Open Value
5.93
150.9
Closing Value
26.66
Upside

Finch Therapeutics Trading Date Momentum on April 27, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Finch Therapeutics Fundamentals Correlations and Trends

By evaluating Finch Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Finch Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Finch financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Finch Therapeutics Stock history

Finch Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Finch is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Finch Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Finch Therapeutics stock prices may prove useful in developing a viable investing in Finch Therapeutics
Last ReportedProjected for 2024
Common Stock Shares Outstanding1.6 B1.7 B
Net Loss-103.2 M-98 M

Finch Therapeutics Quarterly Net Working Capital

25.04 Million

Finch Therapeutics Stock Technical Analysis

Finch Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Finch Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Finch Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Finch Therapeutics Period Price Range

Low
March 14, 2022
High

 5.93 

  

 150.90 

144.972,445%

Finch Therapeutics March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Finch Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Finch Therapeutics shares will generate the highest return on investment. By undertsting and applying Finch Therapeutics stock market strength indicators, traders can identify Finch Therapeutics Group entry and exit signals to maximize returns

Finch Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Finch Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Finch Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Finch to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Finch Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Finch Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Finch Therapeutics Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Finch Therapeutics Group Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Finch Therapeutics Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Finch Therapeutics information on this page should be used as a complementary analysis to other Finch Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Finch Stock analysis

When running Finch Therapeutics' price analysis, check to measure Finch Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Finch Therapeutics is operating at the current time. Most of Finch Therapeutics' value examination focuses on studying past and present price action to predict the probability of Finch Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Finch Therapeutics' price. Additionally, you may evaluate how the addition of Finch Therapeutics to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Is Finch Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Finch Therapeutics. If investors know Finch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Finch Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(61.48)
Revenue Per Share
0.067
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.19)
Return On Equity
(1.26)
The market value of Finch Therapeutics is measured differently than its book value, which is the value of Finch that is recorded on the company's balance sheet. Investors also form their own opinion of Finch Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Finch Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Finch Therapeutics' market value can be influenced by many factors that don't directly affect Finch Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Finch Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Finch Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Finch Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.